Elsevier

Brain Research

Volume 648, Issue 1, 13 June 1994, Pages 99-108
Brain Research

Glucocorticoids potentiate the adenylyl cyclase—cAMP system mediated immunoreactive β-endorphin production and secretion from hypothalamic neurons in culture

https://doi.org/10.1016/0006-8993(94)91910-0Get rights and content

Abstract

Beta-endorphin(βEP)1−31, a potent opioid peptide of proopiomelanocortin (POMC) derivatives, is produced and released from neurons at arcuate nuclei of the rat hypothalamus. Although dexamethasone (DM) suppresses the production and secretion of POMC related peptides from rat pituitary corticotrophs, the effect of glucocorticoids on the function of hypothalamic βEP neurons remains unclear. Employing long term monolayer cultures of neonatal rat hypothalamic cells, we report here that 4 day treatment with 10 μM of forskolin increased ir-βEP levels in cell content and culture media by approximately1.7 (P < 0.05) and 4.1 times (P < 0.01) above vehicle treated control cultures (mean ±S.E.M., 47.3 ± 2.6 pg/well 40.4 ± 3.0 pg/well; n = 3) respectively. Although 4 day treatment with DM alone had little effect on the release and the cell content of ir-βEP, it significantly enhanced forskolin-induced elevation of ir-βEP levels in cell content and in culture media. The effect of DM was dose-related and time-dependent, with an EC50 of about 1 nM; at this concentration DM enhanced ir-βEP secretion about2.1 times (P < 0.01) above that induced by 10 μM of forskolin alone. Furthermore, the potentiating effect of DM was specifically suppressed by 100 nM of RU38486 (P < 0.01), a glucocorticoid receptor antagonist, but not by an equivalent dose of RU28318, a mineralocorticoid receptor antagonist. In addition, Northern blot analysis showed that forskolin (10 μM) increased the abundance of POMC mRNA 1.4 fold above that of vehicle treated control cultures. Whereas by itself, DM (10 nM) had little effect on the level of POMC mRNA, it enhanced forskolin-stimulated increase of the abundance of POMC mRNA approximately 2.6 times. Moreover, DM also augmented1.6 times (P < 0.05) forskolin-induced but not 3-isobutyl-1-methylxanthine (IBMX)-induced increase of cAMP production (5.5 ± 0.4 pmol/well; mean ± S.E.M., n = 3) in the cultures. Taken together, our findings suggest that in contrast to the inhibitory effect on pituitary corticotrophs, glucocorticoids enhance the production and secretion of βEP from rat hypothalamic neurons by facilitating the stimulatory effect mediated, in part, through the adenylyl cyclase-cAMP system.

References (44)

  • EberwineJ.H. et al.

    Complex transcriptional regulation by glucocorticoids and corticotropin-releasing hormone of proopiomelanocortin gene expression in rat pituitary cultures

    DNA

    (1987)
  • FeinsteinP.G. et al.

    Molecular cloning and characterization of a Ca2+ / calmodulin-insensitive adenylyl cyclase from rat brain

  • FinleyJ. et al.

    Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain

    Neuroendocrinology

    (1981)
  • FuxeK. et al.

    Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor

    Endocrinology

    (1985)
  • GagnerJ.P. et al.

    Tissue specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate and glucocorticoids

    Mol. Endocrinology

    (1987)
  • GonzalezG.A. et al.

    A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence

    Nature

    (1989)
  • HoudijkA.P. et al.

    Cyclic nucleotides in human macrophages: effects of atrial natriuretic factor and nitroprusside on cGMP and cAMP production

    Int. J. Tissue React.

    (1991)
  • HuangW. et al.

    Forskolin-induced immunoreactive atrial natriuretic peptide (ANP) secretion and pro-ANP messenger ribonucleic acid expression of hypothalamic neurons in culture: modulation by glucocorticoids

    Endocrinology

    (1991)
  • HuangW. et al.

    Norepinephrine stimulates irANP secretion and pro-ANP mRNA expression from rat hypothalamic neurons in culture: effect of α2-adrenoceptors

    Endocrinology

    (1992)
  • HuangW. et al.

    Ascorbic acid enhances forskolin-induced cyclic AMP production and pro-ANP mRNA expression of hypothalamic neurons in culture

    Endocrinology

    (1993)
  • HuangW. et al.

    Plasticity of adrenoceptor responsiveness on irANP secretion and pro-ANP mRNA expression in hypothalamic neuron cultures: modulation by dexamethasone

    Endocrinology

    (1992)
  • Keller-WoodM.E. et al.

    Corticosteroid inhibition of ACTH secretion

    Endocrine Rev.

    (1984)
  • Cited by (13)

    • Type II glucocorticoid receptors in the ovine hypothalamus: Distribution, influence of estrogen and absence of co-localization with GnRH

      2002, Brain Research
      Citation Excerpt :

      Numerous neuropeptide systems have been implicated in the regulation of GnRH secretion and it is plausible to speculate that cortisol could act on several of these systems. For example, the opioidergic system has been strongly implicated in the steroidal inhibition of GnRH release [14] and glucocorticoids increase in vitro β-endorphin expression and release in rats [43]. Moreover, circulating glucocorticoids acting through GR inhibit LH, in part, through a central action involving endogenous opioid receptors [4] and all β-endorphin neurons possess GR immunoreactivity in the rat [7].

    • cAMP activates transcription of the human glucocorticoid receptor gene promoter

      1998, Journal of Steroid Biochemistry and Molecular Biology
    • The antiglucocorticoid action of mifepristone

      1996, Pharmacology and Therapeutics
    View all citing articles on Scopus
    View full text